Skip to main content
Supplement ScienceSupplementScience

Benefits of Caralluma Fimbriata

Evidence:Preliminary
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Appetite suppression — Kuriyan et al. (2007, n=50) found Caralluma 1 g/day significantly reduced appetite (hunger and desire to eat) vs placebo over 60 days
  • Waist circumference — the same trial showed significant waist circumference reduction in the Caralluma group
  • Fat synthesis inhibition — pregnane glycosides may inhibit citrate lyase and malonyl CoA, reducing de novo lipogenesis (in vitro data)

What the Research Says

Caralluma fimbriata is a natural supplement traditionally used in India for appetite management. Its active compounds, pregnane glycosides, are proposed to influence appetite pathways, providing a plausible mechanism of action (Kuriyan et al., 2007). Clinical evidence, however, remains limited and mixed.

A systematic review and meta-analysis by Jayawardena et al. (2021) analyzed seven clinical trials involving 506 participants, finding that Caralluma fimbriata extract significantly reduced waist circumference (-1.59 cm, p=0.041) and waist-to-hip ratio (-0.06, p=0.05), but did not significantly affect body weight, BMI, or appetite compared to placebo. Similarly, a 2013 systematic review by Astell et al. (2013) of 14 double-blind RCTs concluded that while some plant extracts showed promise for appetite suppression and weight management, only Caralluma fimbriata and Garcinia cambogia plus Gymnema sylvestre combinations demonstrated consistent effects.

More recent studies provide additional insights. A 2021 double-blind, randomized, placebo-controlled trial by Rao et al. (2021) involving 83 overweight adults found that Caralluma fimbriata extract significantly reduced calorie intake, waist circumference, and weight compared to placebo over 16 weeks. Additionally, Kell et al. (2019) reported that the supplement significantly reduced anxiety and stress in a randomized, double-blind trial of 97 healthy adults over eight weeks.

In a specialized population study, Griggs et al. (2015) found that Caralluma fimbriata extract significantly reduced hyperphagia in children and adolescents with Prader-Willi syndrome over four weeks.

Overall, while Caralluma fimbriata shows modest benefits for waist circumference reduction and may aid appetite management, evidence supporting significant weight loss is limited. It may be most effective as part of a broader strategy for appetite control or specific conditions like hyperphagia.

References

  1. RCTKuriyan R, Raj T, Srinivas SK, et al. (2007). Effect of Caralluma fimbriata extract on appetite, food intake and anthropometry in adult Indian men and women. Appetite. DOI PubMed
  2. Meta-analysisJayawardena R, Francis TV, Abhayaratna S, Ranasinghe P (2021). The use of Caralluma fimbriata as an appetite suppressant and weight loss supplement: a systematic review and meta-analysis of clinical trials.. BMC complementary medicine and therapies. DOI PubMed
  3. RCTRao A, Briskey D, Dos Reis C, Mallard AR (2021). The effect of an orally-dosed Caralluma Fimbriata extract on appetite control and body composition in overweight adults.. Scientific reports. DOI PubMed
  4. Kell G, Rao A, Katsikitis M (2019). A randomised placebo controlled clinical trial on the efficacy of Caralluma fimbriata supplement for reducing anxiety and stress in healthy adults over eight weeks.. Journal of affective disorders. DOI PubMed
  5. RCTGriggs JL, Su XQ, Mathai ML (2015). Caralluma Fimbriata Supplementation Improves the Appetite Behavior of Children and Adolescents with Prader-Willi Syndrome.. North American journal of medical sciences. DOI PubMed
  6. RCTAstell KJ, Mathai ML, McAinch AJ, Stathis CG, et al. (2013). A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomised controlled clinical trial.. Complementary therapies in medicine. DOI PubMed
  7. Astell KJ, Mathai ML, Su XQ (2013). Plant extracts with appetite suppressing properties for body weight control: a systematic review of double blind randomized controlled clinical trials.. Complementary therapies in medicine. DOI PubMed